| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Pharmakologie und Toxikologie (G.B., A.B., P.H., H.-G.J., W.B.) and Institut für Biochemie, (I.B., P.C.H.), Medizinische Fakultät der Rheinisch-Westfälische Technische Hochschule Aachen, Aachen D-52057, Germany
Address all correspondence and requests for reprints to: Dr. Walter Becker, Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der Rheinisch-Westfälische Technische Hochschule Aachen, Wendlingweg 2, D-52057 Aachen, Germany. E-mail: walter.becker{at}post.rwth-aachen.de.
Two predominant splice variants of the leptin receptor (LEPR) are coexpressed in leptin-responsive tissues: the long form, LEPRb, characterized as the signal-transducing receptor, and the signaling-defective short form, LEPRa. It is unknown whether heterodimers of these isoforms are capable of signal transduction via the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. To address this question, chimeric receptors were constructed consisting of the transmembrane and intracellular parts of LEPRb and LEPRa fused with the extracellular domains of either the 
- or ß-subunit of the IL-5 receptor. This strategy allows the directed heterodimerization of different LEPR cytoplasmic tails and excludes homodimerization. In COS-7 and HEPG2 cells, chimeric receptor heterodimers of LEPRa and LEPRb failed to activate the JAK/STAT pathway, whereas receptor dimers of LEPRb gave rise to the expected ligand-dependent activation of JAK2, phosphorylation of STAT3, and STAT3-dependent promoter activity. Markedly lower amounts of JAK2 were found to be associated with immunoprecipitated LEPRa chimeras than with LEPRb chimeras. Analysis of a series of deletion constructs indicated that a segment of 15 amino acids in addition to the 29 amino acids common to LEPRa and LEPRb was required for partial restoration of JAK/STAT activation. Site-directed mutagenesis of the critical sequence indicated that two hydrophobic residues (Leu896, Phe897) not present in LEPRa were indispensable for receptor signaling. These findings show that LEPRa/LEPRb heterodimers cannot activate STAT3 and identify sequence elements within the LEPR that are critical for the activation of JAK2 and STAT3.
This article has been cited by other articles:
 |
|
 |
|
  T. Ozbay and R. Nahta A Novel Unidirectional Cross-Talk from the Insulin-Like Growth Factor-I Receptor to Leptin Receptor in Human Breast Cancer Cells Mol. Cancer Res., June 1, 2008; 6(6): 1052 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Adachi, Y. Takemoto, T. Bungo, and T. Ohkubo Chicken leptin receptor is functional in activating JAK-STATpathway in vitro J. Endocrinol., May 1, 2008; 197(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Peters, M. Conrad, C. Hubold, U. Schweiger, B. Fischer, and H. L. Fehm The principle of homeostasis in the hypothalamus-pituitary-adrenal system: new insight from positive feedback Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R83 - R98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Saxena, P. M. Vertino, F. A. Anania, and D. Sharma Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3 J. Biol. Chem., May 4, 2007; 282(18): 13316 - 13325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Saxena, D. Sharma, X. Ding, S. Lin, F. Marra, D. Merlin, and F. A. Anania Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma Cells Cancer Res., March 15, 2007; 67(6): 2497 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mansour, F. G. Pereira, E. P. Araujo, M. E. C. Amaral, J. Morari, N. R. Ferraroni, D. S. Ferreira, I. Lorand-Metze, and L. A. Velloso Leptin Inhibits Apoptosis in Thymus through a Janus Kinase-2-Independent, Insulin Receptor Substrate-1/Phosphatidylinositol-3 Kinase-Dependent Pathway Endocrinology, November 1, 2006; 147(11): 5470 - 5479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Sharma, N K Saxena, P M Vertino, and F A Anania Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer, June 1, 2006; 13(2): 629 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mehebik, A.-M. Jaubert, D. Sabourault, Y. Giudicelli, and C. Ribiere Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation Am J Physiol Cell Physiol, August 1, 2005; 289(2): C379 - C387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ahr, M. Denizot, V. Robert-Hebmann, A. Brelot, and M. Biard-Piechaczyk Identification of the Cytoplasmic Domains of CXCR4 Involved in Jak2 and STAT3 Phosphorylation J. Biol. Chem., February 25, 2005; 280(8): 6692 - 6700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zabeau, D. Defeau, J. Van der Heyden, H. Iserentant, J. Vandekerckhove, and J. Tavernier Functional Analysis of Leptin Receptor Activation Using a Janus Kinase/Signal Transducer and Activator of Transcription Complementation Assay Mol. Endocrinol., January 1, 2004; 18(1): 150 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kloek, A. K. Haq, S. L. Dunn, H. J. Lavery, A. S. Banks, and M. G. Myers Jr. Regulation of Jak Kinases by Intracellular Leptin Receptor Sequences J. Biol. Chem., October 25, 2002; 277(44): 41547 - 41555. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
